Literature DB >> 17963782

Plasma membrane-porating domain in poliovirus 2B protein. A short peptide mimics viroporin activity.

Vanesa Madan1, Silvia Sánchez-Martínez, Natascia Vedovato, Giorgio Rispoli, Luis Carrasco, José L Nieva.   

Abstract

Picornavirus 2B, a non-structural protein required for effective viral replication, has been implicated in cell membrane permeabilization during the late phases of infection. Here, we have approached the molecular mechanism of this process by assessing the pore-forming activity of an overlapping peptide library that spanned the complete 2B sequence. At non-cytopathic concentrations, only the P3 peptide, spanning 2B residues 35-55, effectively assembled hydrophilic pores that allowed diffusion of low molecular mass solutes across the cell plasma membrane (IC(50) approximately 4x10(-7) M) and boundary liposome bilayers (starting at peptide to lipid molar ratios>1:10(4)). Circular dichroism data were consistent with its capacity to fold as a helix in a membrane-like environment. Furthermore, addition of this peptide to a sealed plasma-membrane model, consisting of retinal rod outer segments patch-clamped in a whole-cell configuration, induced ion channel activity within seconds at concentrations as low as 10(-8) M. Thus, we have established a "one-helix" 2B version that possesses the intrinsic pore-forming activity required to directly and effectively permeabilize the cell plasma membrane. We conclude that 2B viroporin can be classified as a genuine pore-forming toxin of viral origin, which is produced intracellularly at certain times post infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963782     DOI: 10.1016/j.jmb.2007.09.058

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  Membrane integration of poliovirus 2B viroporin.

Authors:  Luis Martínez-Gil; Manuel Bañó-Polo; Natalia Redondo; Silvia Sánchez-Martínez; José Luis Nieva; Luis Carrasco; Ismael Mingarro
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Enterovirus 71 2B Induces Cell Apoptosis by Directly Inducing the Conformational Activation of the Proapoptotic Protein Bax.

Authors:  Haolong Cong; Ning Du; Yang Yang; Lei Song; Wenliang Zhang; Po Tien
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 3.  An inside job: subversion of the host secretory pathway by intestinal pathogens.

Authors:  Tyler M Sharp; Mary K Estes
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

4.  PepFect14 Signaling and Transfection.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2022

5.  Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release.

Authors:  Kate Hsu; Jin Han; Krekwit Shinlapawittayatorn; Isabelle Deschenes; Eduardo Marbán
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

Review 6.  Cis-active RNA elements (CREs) and picornavirus RNA replication.

Authors:  Benjamin P Steil; David J Barton
Journal:  Virus Res       Date:  2008-09-20       Impact factor: 3.303

7.  Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro.

Authors:  Hannah Armer; Katy Moffat; Thomas Wileman; Graham J Belsham; Terry Jackson; W Paul Duprex; Martin Ryan; Paul Monaghan
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

Review 8.  Mechanistic Landscape of Membrane-Permeabilizing Peptides.

Authors:  Shantanu Guha; Jenisha Ghimire; Eric Wu; William C Wimley
Journal:  Chem Rev       Date:  2019-01-09       Impact factor: 72.087

Review 9.  Viroporins, Examples of the Two-Stage Membrane Protein Folding Model.

Authors:  Luis Martinez-Gil; Ismael Mingarro
Journal:  Viruses       Date:  2015-06-26       Impact factor: 5.048

10.  Viroporin Activity of the Foot-and-Mouth Disease Virus Non-Structural 2B Protein.

Authors:  Da Ao; Hui-Chen Guo; Shi-Qi Sun; De-Hui Sun; To Sing Fung; Yan-Quan Wei; Shi-Chong Han; Xue-Ping Yao; Sui-Zhong Cao; Ding Xiang Liu; Xiang-Tao Liu
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.